The final diagnosis was GBM, IDH-wild type, WHO grade IV, based on the 2016 World Health Organization (WHO) classification of central nervous system (CNS) tumors and cIMPACT-NOW workgroup. The gene discussed is IDH2; the disease is glioblastoma.